Turning Point Benefit Group, Inc. Corcept Therapeutics Inc Transaction History
Turning Point Benefit Group, Inc.
- $166 Billion
- Q3 2025
A detailed history of Turning Point Benefit Group, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Turning Point Benefit Group, Inc. holds 3 shares of CORT stock, worth $226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$226% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
480Shares Held
80.5MCall Options Held
599KPut Options Held
710K-
Black Rock Inc. New York, NY16.5MShares$1.25 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.54MShares$720 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.7MShares$582 Million20.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.09MShares$460 Million0.72% of portfolio
-
Parallel Advisors, LLC3.87MShares$292 Million6.09% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.09B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...